study question: Is it possible to detect associated deep infiltrating endometriosis (DIE) before surgery for patients operated on for endometriomas using a preoperative clinical symptoms questionnaire? summary answer: A diagnostic score of DIE associated with endometriomas using four clinical symptoms defined a high-risk group where the probability of DIE was 88% and a low-risk group with a 10% probability of DIE.
Introduction
Endometriosis is a common gynaecological pathology that can cause disabling pain (Fauconnier and Chapron, 2005) and reproductive failure (de Ziegler et al., 2010) . It is defined as the presence of endometrial cells that have grafted and grown outside the uterine cavity (Sampson, 1927) , reaching not only the reproductive system, but also the neighbouring organs of the abdominopelvic cavity (gastrointestinal system and urinary tract). Infiltration of cells to these further systems defines the development of deep infiltrating endometriosis (DIE). Different forms of endometriosis have been described , which raises different problems for both the diagnosis and treatment of this disease: (i) superficial endometriosis, which implants in the area of the peritoneum, (ii) endometriosis characterized by deep penetration of lesions underneath the peritoneum, where the lesion is often multifocal and reaches several organs and (iii) the ovarian cyst or endometrioma. All of these forms are characterized by the same histological lesion, which involves the penetration of the stroma and glands to various depths within the tissues (Kamergorodsky et al., 2009) .
The diagnosis of endometrioma is easily performed using a transvaginal ultrasound, which has a sensitivity of 90% and a specificity of 97% (Guerriero et al., 2007) . DIE is difficult to diagnose, and there is an important diagnosis delay for endometriosis (Hadfield et al., 1996; Husby et al., 2003) , especially when the disease is severe (Matsuzaki et al., 2006) . This form requires more specialized radiological assessments and a combinatorial approach (ultrasonography, magnetic resonance imaging (MRI) and rectal endoscopic ultrasonography) (Kinkel et al., 1999; Abrao et al., 2007; Piketty et al., 2009) to detect the DIE lesions preoperatively. These tests are expensive and sometimes poorly accepted by patients. In practice, there is a wide disparity in the radiological and endoscopic exploration of patients that undergo surgery for endometriosis cysts. In non-specialized centres, endometriomas are often operated on without any of these examinations, and DIE lesions are discovered intra-operatively, which does not allow for optimal treatment. On the other hand, in specialized centres, all of these imaging tests are often routinely ordered, resulting in an excess of unnecessary radiological examinations in patients at low risk of DIE.
Both forms of endometriosis (endometrioma and DIE) are often associated with one another (Somigliana et al., 2004; Chapron et al., 2009) , and only simultaneous excision of both types of lesions is effective in pain removal and a low rate of recurrence. In a study of 100 patients that had complete excision of the DIE lesions, the recurrence rate was 2% at 5 years post-surgery (Dousset et al., 2010) . The rate of recurrence is due to incomplete excision (Abbott et al., 2003) and the growth of DIE lesions after surgery (Fedele et al., 2005) , which contribute to persistent or recurrent pain and impact the quality of life (Garry et al., 2000) . Therefore, it is important to preoperatively diagnose patients that are at risk of having DIE lesions associated with endometrioma and to perform the appropriate radiologic imaging to guide the best surgical management (Chapron et al., 2012) . Analysis of preoperative clinical data to determine which characteristics are associated with DIE has been the subject of only a few studies and failed to demonstrate a good diagnostic performance in DIE detection. However, several symptoms have been shown to be associated with DIE. Pain has been recognized by several studies as the main symptom of DIE lesions (Porpora et al., 1999; Fauconnier et al., 2002) and there is a strong association between DIE and the intensity of the pain (Koninckx et al., 1991; Chapron et al., 2003; Chopin et al., 2006) , as well as the association of different types of pain (dyspareunia, dysmenorrhoea and pelvic pain) with increased risk of DIE (Sinaii et al., 2008) . Some of the pain symptoms are related to specific anatomic localizations (Fauconnier and Chapron, 2005) . The association of infertility with pain has also been related to the diagnosis of DIE (Forman et al., 1993) . In addition, the clinical symptoms and medical history during adolescence differ for those found to have DIE during surgery compared with those who did not (Chapron et al., 2011) . However, all of the clinical characteristics associated with DIE have never been combined to enable prediction of the presence of DIE.
The aim of our study was to build a clinical model for the preoperative prediction of the association of DIE with endometrioma using a questionnaire focused on standardized preoperative symptoms and risk factors of the disease. The definition of this model will aid in the detection of DIE lesions in high-risk patients before surgery for endometrioma and will also decrease the use of unnecessary examinations in low-risk patients.
Methods
This was a single centre prospective study in a gynaecology department of a teaching hospital that specialized in endometriosis.
Patients
The population of patients was extracted from a prospective database and included all patients 18 -42 years old that underwent gynaecological surgery by laparotomy or laparoscopy from January 2005 to October 2011 (excluding surgeries for cancer, pregnancy and prolapse). We extracted the patients from the database according to histological and surgical criteria: histological diagnosis of endometrioma and complete excision of the endometriotic lesions:
-Inclusion criteria were patients with histological diagnosis of endometriosis lesions that had, according to the findings of the operator, a complete treatment of endometriotic lesions. -Exclusion criteria were incomplete surgical exploration that did not allow the exclusion of DIE.
Gold standard
The diagnosis and classification of the lesions were based on the macroscopic surgical results and a histological examination of the lesions where an excision was performed. A macroscopic anatomical classification was carried out according to a previously described method . The histological diagnosis was based on characteristics previously defined in a standardized histological description, comprising the combination of endometrial glands and stroma (Kamergorodsky et al., 2009) . The combination of macroscopic and histological data served as a reference for the definition of the lesions and the classification of patients (endometrioma and associated DIE lesions). Patients were defined to be DIE+ if they met the criteria of the gold standard (macroscopic lesions and histological diagnosis according to the previous description), regardless of the side or the number of endometriomas.
The patients included in the study were divided into two groups: patients that underwent surgery for an endometrioma associated with DIE (DIE+) and patients that underwent surgery and were not associated with DIE lesions (DIE2).
Data collection
The aim of the study was to build a score that could predict DIE based on clinical symptoms; the score was built using variables from the preoperative questionnaire independently of other possible preoperative tests ordered later by the surgeon. The answers from the standardized preoperative questionnaires were prospectively collected.
The patient was referred by a physician or a gynaecologist with an ultrasound from a non-specialized radiologic centre and a diagnosis of an ovarian cyst. At the first preoperative visit, the patient's questionnaire was completed. At that time, the surgeon did not know whether the diagnosis was an endometrioma or another kind of ovarian cyst and whether there was an associated DIE or not.
We developed a database with the collected answers to three standardized questionnaires: (i) a preoperative questionnaire of all patients who had procedures by laparotomy or laparoscopy, regardless of the surgical indication (apart from cancer, pregnancy and prolapse), (ii) a post-operative questionnaire completed by the surgeon performing the procedure, including a description of the macroscopic surgical endometriotic lesions (lesion assessment, staging and samples taken) and (iii) a questionnaire that included the findings from the pathological examination of the surgical excisions.
(i) The patient's questionnaire was a preoperative questionnaire completed at the first preoperative consultation by the surgeon in charge of the patient. It contained 57 variables, including:
-General data: age, BMI, family history, surgical history, obstetrical history and smoking habits. -Gynaecological data: characteristics about the menstrual cycle (length and regularity) and menstruation (menorrhagia and total length of menstruation), the existence of a primary or secondary dysmenorrhoea, and the existence of primary or secondary infertility. -History of symptoms and treatments during adolescence: age at menarche, primary dysmenorrhoea and its consequences on life (absenteeism from school and loss of consciousness), medication by analgesics and whether non-steroidal anti-inflammatory drugs and the oral contraceptive pill (OCP) were necessary, duration of treatments, and age at prescription. 'OCP prescription for severe primary dysmenorrhoea' refers to the history of prescription use during adolescence. -The characteristics of all pains, both menstrual and non-menstrual: the presence or absence of pain, its duration and the worsening of a secondary dysmenorrhoea. Five painful symptoms were measured by five visual analogue scales (VAS) from 0 to 10 (Peveler et al., 1996) . They related to primary or secondary dysmenorrhoea, dyspareunia, pain of gastrointestinal (GI) origin, pain from urinary tract symptoms and noncyclic chronic pelvic pain. Patients were asked at the first preoperative visit about their worst pain in the last 6 months. For patients using hormonal treatment before surgery, VAS pain scores were evaluated regardless of any treatment. If patients had no menstruation for .6 months, the dysmenorrhoea VAS score was 0, as well as other variables defined by cyclic variations. If patients had no sexual activity, the dyspareunia VAS score was 0.
The variable 'pain' was defined by the presence of at least 6 months of dysmenorrhoea, and/or intermenstrual pelvic pain, and/or dyspareunia .
Primary dysmenorrhoea was defined as painful menstruations occurring shortly after menarche, though it could also occur as late as 1 year after menarche (Dawood, 2006) . Secondary dysmenorrhoea was defined as painful menstruations occurring later. 'Worsening of a secondary dysmenorrhoea' was defined according to the patient's evaluation, as long as she was able to give the duration of the worsening symptoms.
Infertility was defined by at least 12 months of unprotected intercourse in which pregnancy was not achieved (Marcoux et al., 1997) . Patients were coded as non-infertile if they did not try to get pregnant.
The GI symptoms were defined as pain when defecating at the time of menstruation or intestinal cyclic pain. If the patient had no menstruation for .6 months, the GI symptoms could not be evaluated during menstruation or during the cycle, and the VAS score was then coded 0.
Chronic pelvic pain was defined as noncyclic pain located in the pelvic area, apart from dyspareunia.
Menorrhagia was defined as 'heavy bleeding' during menstruations according to the patient's evaluation (Warner et al., 2004) . The 'length of menstruation' was another variable indicating the number of days of menstruation, which was independent of the patient's opinion.
-Other questions about possible symptoms related to endometriosis: rectal bleeding and haematuria. -Finally, details of treatments prescribed were collected: mode of contraception, treatment for endometriosis (progestins, OCP, GnRH agonist, etc.) and their details of prescription (current or past use, age at the time of prescription, and duration).
A study of the correlation between the variables and their localizing value which had been previously demonstrated (Fauconnier and Chapron, 2005) led us to create a composite variable from the VAS of GI symptoms and the VAS of dyspareunia. Two variables were combined to define severe dysmenorrhoea: 'OCP prescription for treatment of severe primary dysmenorrhoea' and 'worsening of secondary dysmenorrhoea.
(i) This questionnaire was completed post-operatively by the surgeon using a form for a standardized description of the lesions visualized, their size, their location, their number, their character (deep versus superficial), the existence of adhesions, and whether the pouch of Douglas was obliterated. The completeness of the excision, staging of the lesions, samples taken and their location were all specified. These data were used for the macroscopic diagnosis of the lesions. (ii) This questionnaire was completed post-operatively and included histological findings and confirmation of endometriosis within the surgically excised lesions. Pathologists were unaware of the clinical symptoms. These data were used for the final diagnosis and classification of patients.
Written consent was obtained from the included patients, and the constitution of the database was authorized by the ethics committee (Advisory Committee on Protection of Persons in Biomedical Research) of Cochin Hospital, Paris, France.
Statistical methods
A random sample of two-thirds of the patients was obtained prior to the analysis to develop a clinical prediction model (training sample), leaving one-third of the patients for validation (validation sample). We first performed a univariate analysis comparing DIE+ and DIE2 patients from the training sample for each variable of the preoperative questionnaire, using a quantitative (Student's t-test) or qualitative (x 2 test) test as appropriate. Continuous variables associated with the presence of a DIE at a threshold of P , 0.10 were then converted into dichotomous variables using receiver operating characteristic (ROC) curves. Crude diagnostic odds ratios (OR) were calculated for each variable significantly associated with the diagnosis of a DIE. The diagnostic performance of each variable was assessed using sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR2) and the C-index. We then used a multiple logistic regression to select the best combination of variables that was independently associated with the diagnosis of DIE (P , 0.05). Variables were selected by a backward, stepwise procedure from those significantly associated with DIE in the univariate analysis at a threshold of P , 0.10. Adjusted diagnostic odds ratios (aDOR) were calculated with their 95% confidence intervals (95% CI).
A jackknife procedure was applied to the model to detect variables potentially responsible for instability in the model and that had to be removed (Efron and Gong, 1983) . The performance of the final model in the prediction of DIE was specified by calculating its sensitivity, specificity and area under the curve. The calibration of the model was evaluated using the HosmerLemeshow test (Lemeshow and Hosmer, 1982) .
We then built a score by rounding up the b coefficients from the multivariate analysis (Coste et al., 1997) . The C-index of the logistic regression model and score model were compared to verify that the rounded coefficients did not change the results from the model.
We classified patients as high risk or low risk by choosing two threshold values of the score to make two classifications, one with sensitivity high enough to provide an overall LR+ of ≥4.0 and the other maximizing specificity to allow a LR2 of ≤0.25 (Buckley et al., 1998) .
Finally, the score was applied to the validation sample. The sensitivity and specificity of the score, as well as the probabilities of DIE, in the high-risk and the low-risk groups were compared with those obtained from the training sample.
Statistical analyses were performed using STATA statistical software version 12.1 (Stata Corp.; College Station, TX, USA).
Results
For our study, 343 patients met the inclusion criteria; however, 17 patients were excluded because surgical exploration was considered incomplete due to partial or complete obliteration of the pouch of Douglas. Without complete exploration, it would not be possible to perform the complete excision of the lesions. Of the remaining 326 patients, 162 patients showed no associated DIE lesions (DIE2) and 164 patients had DIE lesions associated with endometrioma (DIE+), based on the histological criteria of the surgical excision of the organs (Table I) .
After a random selection, the training sample included 211 patients: 101 patients DIE+ and 110 patients DIE2; the validation sample included 115 patients: 63 patients DIE+ and 52 patients DIE2. The main characteristics of the DIE+ and DIE2 patients from the derivation dataset are summarized in Table II . A univariate analysis comparing the DIE+ and DIE2 patients did not reveal any significant differences in the general variables (age, BMI, gravidity, parity and family history). Indeed, the variables significantly associated with DIE in the univariate analysis were all variables related to pain (presence of pain, duration of pain and intensity of the five types of pain evaluated by VAS), infertility, symptoms/treatment history during adolescence, the severity of primary dysmenorrhoea as assessed by the need to prescribe estrogenprogestin, and the severity of secondary dysmenorrhoea as evaluated by the notion of worsening.
Prior history of surgery for endometrioma and/or endometriosis was more frequent in DIE+ patients, but we did not find a significant interaction of past surgery on the relationship between VAS scores and DIE (data shown in Supplementary data, Table SI ).
There were significantly more DIE+ patients using hormonal treatments at the time of surgery, but the VAS scores were not lower for the patients using treatment (data shown in Supplementary data, Tables SII and SIII Several localizations can be associated in the same patient, the diagnosis is based on histological findings of surgical specimen, and the lumen of the organs was entered.
Most of the VAS scores were complete, except for 10 missing values for dyspareunia that were input as absent. There were very few missing values for other variables (,5% for all variables), and no significant correlation was found between a class of missing values and the variable of interest (DIE); all missing values were coded 0 by simple imputation.
Dichotomous categorical variables significantly associated in the univariate analysis with DIE (P , 0.10) were evaluated for their diagnostic performance. Continuous variables significantly associated in the univariate analysis with DIE (P , 0.10) were dichotomized using ROC curves, and their diagnostic performance was then also evaluated; their sensitivity, specificity, LR+ and LR2 are shown in Table III .
The composite variable (GI symptoms ≥5 or deep dyspareunia .5) was statistically different between DIE+ and DIE2 patients (P , 0.001; Table III ). The variable 'severe dysmenorrhoea' previously defined was statistically different between DIE+ and DIE2 patients (P , 0.001; Table III diagnosis of DIE, namely duration of pain, severe dysmenorrhoea, VAS GI pain or dyspareunia, infertility, VAS urinary symptoms and menorrhagia (Table IV) . Among these variables, two (VAS urinary symptoms and menorrhagia) were unstable according to the jackknife procedure, and we therefore removed them from the model. A simplified model with four variables was finally selected and had a diagnostic performance close to the full model (Table IV) . The C-index of this model was 0.84 (95% CI 0.79 -0.90) and the Hosmer -Lemeshow test confirmed the suitability of the model for the data (P ¼ 0.23). We used the b coefficients from the logistic regression and rounded and multiplied by 10 for easier use. The DIE score (Table V) was then given by the following equation:
Score ¼ [(dyspareunia VAS .5 or GI symptoms VAS ≥5) × 18] + (pain duration .24 months × 13) + (severe dysmenorrhoea × 13) + (existence of infertility × 9). There were no significant losses of fit due to rounding the coefficient, as shown by the C-index score of 0.84 (95% CI 0.79 -0.90), which was similar to the C-index of the logistic regression model (P ¼ 0.74).
We then defined a low-and high-risk group of DIE by choosing two cut-off points of the score, with an LR2 ≤0.25 and an LR+ ≥4:
-Patients with a score of ,13 were defined as a low-risk group, where the probability of DIE was 10% (95 CI 7-15). A threshold score value of 13 produced a sensitivity of 95% (95% CI 89-98) and a specificity of 42% (95% CI 32-52), with LR2 equal to 0.1 (95% CI 0.0 -0.3). -Patients with a score ≥35 were defined as a high-risk group, where the probability of DIE was 88% (95% CI 83-92). A threshold value of 35 produced a specificity of 94% (95% CI 87-97) and a sensitivity of 51% (95% CI 41-62), with a LR+ of 8.1 (95% CI 3.9 -17).
Next, the score was calculated for the patients in the validation sample (Fig. 1) . The observed percentages of DIE were in the expected range: 11% in the low-risk group and 90% in the high-risk group. The C-index of the score for the prediction of DIE (0.84, 95% CI 0.76 -0.91) was not significantly different from the C-index of the training sample (0.84, 95% CI 0.79 -0.90; P ¼ 0.99) (Fig. 2) .
Discussion
In this study, we developed a prediction score for the presence of DIE associated with endometriotic cysts based on a simple preoperative questioning of the patient with four variables: dyspareunia VAS score .5 or GI symptoms ≥5 (coefficient: 18); duration of pain for over 24 months (coefficient: 13); prescription of OCP for severe primary dysmenorrhoea or worsening of secondary dysmenorrhoea (coefficient: 13); and primary or secondary infertility (coefficient: 9 Infertility: at least 12 months of unprotected intercourse which did achieve pregnancy coded 'no' if the patient does not desire to get pregnant ; pain: presence of at least 6 months of dysmenorrhoea and/or dyspareunia and/or NCPP and/or GI pain; GI symptoms ¼ pain when defecating at the time of menstruation or intestinal cyclic pain; severe dysmenorrhoea ¼ OCP for primary dysmenorrhoea or worsening of secondary dysmenorrhoea; primary dysmenorrhoea: menstruations occurring shortly after menarche (up to 1 year), secondary dysmenorrhoea occurs later; menorrhagia: heavy bleeding according to the patient. Se, sensibility; Sp, specificity; OR, odds ratio; LR, likelihood ratio.
and added to get the score ranging from 0 (0 + 0 + 0 + 0) to 53 (18 + 13 + 13 + 9). The choice of two cut-off points to define a population at low risk (score ,13) and a population at high risk (score ≥35) provided a clinical prediction rule with a good diagnostic performance: the low-risk cut-off point defined a model with a sensitivity of 95%, and the high-risk cut-off point defined a model with a specificity of 94%.
This classification offers the advantage of avoiding unnecessary radiological investigations in patients at low risk of DIE, while tracking the largest number of patients that require specific surgical management for associated DIE. The choice between the two score cut-off points (with high sensitivity or with high specificity) to order radiological investigations depends on the main objectives set in advance: the clinical and economic context or the personal choice of the patient.
On the whole, the high sensitivity model would have avoided unnecessary radiological explorations for 30% of the controls, while 97% of DIE would have been detected. This model should be used by specialized surgical services, where examinations are usually almost always undertaken. This will target the patient population where it is not necessary to use a complete radiological investigation.
The high specificity model would have avoided unnecessary radiological explorations for 91% of the controls, while 51% of DIE would have been detected. This model should be used by less specialized teams for whom investigations are in practice rarely ordered. This will target the high-risk patients for whom assessment is essential for proper surgical management.
We did not build a single score for every organ; instead, we defined a population at high risk of DIE who would need a complete radiologic evaluation, including at least an MRI and computed tomography scan and, based on imaging results and clinical symptoms, more specific explorations (rectal endoscopic ultrasonography and uro-CT scan). Duration of pain .24 months 3.8 1.9-7.7 0.000 VAS dyspareunia .5 or GI symptoms ≥5 6.0 2.9-12.1 0.000
Severe dysmenorrhoea 3.8 1.9-7.6 0.000
Infertility (primary or secondary) 2.5 1.2-4.9 0.015
Infertility: at least 12 months of unprotected intercourse which did not achieve pregnancy coded 'no' if the patient does not desire to get pregnant; pain: presence of at least 6 months of dysmenorrhoea and/or dyspareunia and/or chronic pelvic pain and/or GI pain; GI symptoms ¼ pain when defecating at the time of menstruation or intestinal cyclic pain; severe dysmenorrhoea ¼ OCP for primary dysmenorrhoea or worsening of secondary dysmenorrhoea; primary dysmenorrhoea: menstruations occurring shortly after menarche (up to 1 year), secondary dysmenorrhoea occurs later; menorrhagia: heavy bleeding according to the patient. AUC, area under the receiver operating characteristic curve; aOR, adjusted odd ratio; CI, confidence interval. GI symptoms ¼ pain when defecating at the time of menstruation or intestinal cyclic pain; pain ¼ presence of at least 6 months of dysmenorrhoea and/or dyspareunia and/or NCPP and/or GI pain; severe dysmenorrhoea ¼ OCP prescription for severe primary dysmenorrhoea or worsening of a secondary dysmenorrhoea; primary dysmenorrhoea: menstruations occurring shortly after menarche, secondary dysmenorrhoea occurs later; infertility : at least 12 months of unprotected intercourse which did not achieve pregnancy coded 'no' if the patient does not desire to get pregnant.
This classification is easy and helpful for the surgeon, gynaecologist or general practitioner to decide whether to order radiological investigations and whether to refer the woman to a specialized surgical centre. Our study confirms previously published studies on pain, infertility and disease history. Indeed, the variables in the final model have been the subject of previous studies, whose findings are in agreement with our results: pain is recognized as a key symptom of the disease, particularly for DIE (Vercellini et al., 1996 (Vercellini et al., , 2007 . Different types of pain have been shown to correspond to specific locations of the disease. For example, dyspareunia and pain with defecation are correlated and significantly related to the presence of a nodule in the rectovaginal septum (Fauconnier and Chapron, 2005) , which could justify the creation of a composite variable from these two parameters. The combination of endometrioma and pain is significantly related to the simultaneous presence of DIE Chapron et al., 2012) . Infertility, when combined with pelvic pain, has been shown to be often associated with DIE (Koninckx et al., 1991) . The history of patients at the time of adolescence has revealed that some events or symptoms in early menstruation are statistically more frequently associated with a later surgical diagnosis of DIE (Chapron et al., 2011) . The duration of pain and other related symptoms are also often associated with the existence of DIE (Hadfield et al., 1996; Husby et al., 2003) . Our study confirmed all of these findings and in combining them, provided a good prediction of DIE in a group of patients that underwent surgery for an endometrioma.
The strength of this study lies in its prospective assessment of pain using a standardized questionnaire that employed visual scales validated for each type of pain known to be associated with endometriosis. Furthermore, the diagnosis of DIE was based on strict criteria: all patients underwent complete surgical exploration, and diagnosis was always confirmed histologically. The choice of a population with a surgical indication related to the presence of an endometrioma minimized the selection bias of DIE due to surgical recruitment; in most studies on endometriosis, the main problem with selecting patients based on a histological diagnosis is that only patients having surgery are included in the study. The indication for surgery for DIE depends on the characteristics of DIE, such as the intensity of pain or specific localization, creating a bias of selection. However, most ovarian cysts are an indication for surgery independently of associated DIE characteristics, thereby minimizing the bias selection for DIE patients.
The population of 163 patients with DIE and associated endometrioma allowed us to use a validation sample without any prejudice for the power of the study. Internal validation of the model limits the possibility of a model overfitting the data. Random selection of one-third of the population for validation of the model built on the other two-thirds enabled this validation. In addition, the estimate of the variance of the coefficients by the jackknife method avoided the use of variables responsible for instability of the model, which might have affected the results of the logistic regression model (Huchon et al., 2010) . These two methods provided two strong ways of validation. The results from the validation . The four variables dyspareunia VAS score .5 or GI symptoms . or ¼ 5 (coefficient: 18); duration of pain for over 24 months (coefficient: 13); prescription of OCP for severe primary dysmenorrhoea or worsening of secondary dysmenorrhoea (coefficient: 13); and primary or secondary infertility (coefficient: 9) take the value 0 if absent or 1 if present; they are multiplied by their coefficients and added to get the score ranging from 0 (0 + 0 + 0 + 0) to 53 (18 + 13 + 13 + 9). Values on the x-axis are all the possible values of the score. VAS, visual analogue scale; GI, gastrointestinal; OCP, oral contraceptive pill. GI symptoms ¼ pain when defecating at the time of menstruation or intestinal cyclic pain; pain ¼ presence of at least 6 months of dysmenorrhoea and/or dyspareunia and/or non-chronic pelvic pain and/or gastro-intestinal pain; severe dysmenorrhoea ¼ OCP prescription for severe primary dysmenorrhoea or worsening of a secondary dysmenorrhoea; primary dysmenorrhoea: menstruations occurring shortly after menarche, secondary dysmenorrhoea occurs later; infertility: at least 12 months of unprotected intercourses which did not allow to achieve pregnancy coded 'no' if the patient does not desire to get pregnant. sample were in perfect agreement with those from the training sample and had very good diagnostic performance.
However, our study may have several limitations that arise from the evaluation of the four variables selected to determine the score. Using a duration of pain of 24 months might seem paradoxical, as ideally we want to make an early diagnosis. One could argue that according to our score, a DIE patient considered at high risk because of duration of pain for .24 months would be classified as low risk a few months earlier with the same disease. However, this duration was based on the population sample using the ROC curve to maximize sensitivity and specificity to detect DIE. According to many previous studies, there is a significant delay in the diagnosis of endometriosis that averages 7-12 years despite many complaints of patients seeking medical assistance throughout the world (Ballard et al., 2006) . This is why a period of 24 months, even though it may appear long, will allow a much earlier diagnosis than before. For patients with no desire to get pregnant, we could not determine whether they were infertile. Therefore, we considered them as fertile for the analysis to potentially minimize the difference between DIE+ and DIE2 patients for this parameter. As a consequence, this minimized the coefficient and the aOR of the infertility variable. The coefficient of the infertility variable was 9, which could have been an underestimate.
Patients that were using treatment before surgery might have little or no pain, particularly if they have no menstruation using hormonal treatments and are coded as no pain for dysmenorrhoea and for all cyclic pains. However, even if they were underestimated, patients undergoing treatment with or without amenorrhoea still had significantly higher pain scores than those without treatment, both in the DIE+ and in DIE2 patients. This reflects the severity of the disease more than the result of their treatment (Supplementary data, Tables SII and SIII).
Our study could also be subject to bias. During questioning at the first preoperative visit, the surgeon may have had a high suspicion of the diagnosis because of the typical symptoms described by the patient or be aware of the diagnosis in cases of prior surgery. This could influence the questioning of the patient and create an ascertainment bias. The difference between DIE+ and DIE2 could therefore be artificially increased. For this reason, we were careful to check that a previous surgery did not change the OR of DIE for pain symptoms.
In addition, patients were recruited from a specialized centre where they could be specifically referred for surgical treatment of DIE. Patients in this series were referred initially for an ovarian cyst or an endometrioma. The selection of a population with endometrioma minimized the selection bias for indication of surgery because almost all endometriomas are treated with surgery. However, in this series, there is a high prevalence of associated DIE, especially GI tract lesions, which could influence the OR of predicted variables by increasing the difference between cases and controls and increasing the coefficients of the score.
Finally, misclassifications could have occurred. The description of the localization of DIE lesions in Table I is based on histological findings after the surgical removal of the lesions to provide the most reliable diagnostic test. The gold standard for diagnosis was then based on two steps, which included a macroscopic surgical diagnosis by palpation and visualization and a histological confirmation of the diagnosis on the surgical lesions removed to minimize any bias. However, in spite of the experience of the surgeon, some lesions could have potentially gone undetected. This would result in a misclassification of the DIE lesions and/or a misclassification of the DIE+ patients as DIE2, which would have minimized the difference between the cases and controls.
In summary, all of these biases could modify the score by increasing or decreasing the OR of the DIE, modifying the choice of variables, and modifying the coefficients of the variables. We evaluated these potential consequences and tried to minimize them as much as possible: we used a jackknife procedure and a validation sample, and we evaluated the influence of a previous surgery and of treatments with no significant interaction on the relationship between DIE and symptoms. We reduced the sampling bias of the surgical indication by specifically using a population of patients with endometrioma. The high prevalence of DIE, especially localized in the GI, could have influenced the choice of variables, but the application of this score on this population should predict at least the patients with the same characteristics with the same sensibility and specificity. Despite our efforts to analyse and reduce biases, an external validation on a population with a different prevalence of DIE and a different distribution of lesions will be necessary before generalization of the score. This is the first clinical model proposed to determine the likelihood of having DIE endometriosis from the ultrasound diagnosis of an ovarian cyst. The model defined with our four variables is simple to use in clinical practice and has good diagnostic performance. We postulate that DIE+ patients without endometrioma could be detected by the same score, as long as the presence of an endometrioma does not affect the clinical symptoms of DIE (Chapron et al., 2012) . This hypothesis should be tested in further studies.
Conclusion
We built a predictive score of associated DIE in patients that underwent surgery for an endometriosis cyst with a good diagnostic predictive performance. External validation of these results is necessary in less specialized departments for the management of DIE.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org/.
